These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20418027)

  • 1. Weekly dose-volume parameters of mucosa and constrictor muscles predict the use of percutaneous endoscopic gastrostomy during exclusive intensity-modulated radiotherapy for oropharyngeal cancer.
    Sanguineti G; Gunn GB; Parker BC; Endres EJ; Zeng J; Fiorino C
    Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):52-9. PubMed ID: 20418027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience.
    de Arruda FF; Puri DR; Zhung J; Narayana A; Wolden S; Hunt M; Stambuk H; Pfister D; Kraus D; Shaha A; Shah J; Lee NY
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):363-73. PubMed ID: 15925451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sparing the larynx and esophageal inlet expedites feeding tube removal in patients with stage III-IV oropharyngeal squamous cell carcinoma treated with intensity-modulated radiotherapy.
    Amin N; Reddy K; Westerly D; Raben D; DeWitt P; Chen C
    Laryngoscope; 2012 Dec; 122(12):2736-42. PubMed ID: 22991101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck.
    Caudell JJ; Schaner PE; Desmond RA; Meredith RF; Spencer SA; Bonner JA
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):403-9. PubMed ID: 19467801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy dose-volume parameters predict videofluoroscopy-detected dysphagia per DIGEST after IMRT for oropharyngeal cancer: Results of a prospective registry.
    Kamal M; Mohamed ASR; Volpe S; Zaveri J; Barrow MP; Gunn GB; Lai SY; Ferrarotto R; Lewin JS; Rosenthal DI; Jethanandani A; Meheissen MAM; Mulder SL; Cardenas CE; Fuller CD; Hutcheson KA;
    Radiother Oncol; 2018 Sep; 128(3):442-451. PubMed ID: 29961581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of radiotherapy and chemotherapy on the risk of mucositis during intensity-modulated radiation therapy for oropharyngeal cancer.
    Sanguineti G; Sormani MP; Marur S; Gunn GB; Rao N; Cianchetti M; Ricchetti F; McNutt T; Wu B; Forastiere A
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):235-42. PubMed ID: 22104358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Candidate dosimetric predictors of long-term swallowing dysfunction after oropharyngeal intensity-modulated radiotherapy.
    Schwartz DL; Hutcheson K; Barringer D; Tucker SL; Kies M; Holsinger FC; Ang KK; Morrison WH; Rosenthal DI; Garden AS; Dong L; Lewin JS
    Int J Radiat Oncol Biol Phys; 2010 Dec; 78(5):1356-65. PubMed ID: 20646872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysphagia disorders in patients with cancer of the oropharynx are significantly affected by the radiation therapy dose to the superior and middle constrictor muscle: a dose-effect relationship.
    Levendag PC; Teguh DN; Voet P; van der Est H; Noever I; de Kruijf WJ; Kolkman-Deurloo IK; Prevost JB; Poll J; Schmitz PI; Heijmen BJ
    Radiother Oncol; 2007 Oct; 85(1):64-73. PubMed ID: 17714815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of larynx-sparing techniques with IMRT when treating the head and neck.
    Webster GJ; Rowbottom CG; Ho KF; Slevin NJ; Mackay RI
    Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):617-22. PubMed ID: 18793966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of methods to reduce dose to swallowing-related structures in head and neck cancer.
    Caudell JJ; Burnett OL; Schaner PE; Bonner JA; Duan J
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):462-7. PubMed ID: 19577862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume.
    Chao KS; Ozyigit G; Blanco AI; Thorstad WL; Deasy JO; Haughey BH; Spector GJ; Sessions DG
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):43-50. PubMed ID: 15093897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of radiation dose to pharyngeal constrictor muscles on late dysphagia and quality of life in patients with locally advanced oropharyngeal carcinoma.
    Mogadas S; Busch CJ; Pflug C; Hanken H; Krüll A; Petersen C; Tribius S
    Strahlenther Onkol; 2020 Jun; 196(6):522-529. PubMed ID: 32006068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spinal cord planning risk volumes for intensity-modulated radiation therapy of head-and-neck cancer.
    Breen SL; Craig T; Bayley A; O'Sullivan B; Kim J; Jaffray D
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):321-5. PubMed ID: 16377418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tongue-out versus tongue-in position during intensity-modulated radiotherapy for base of tongue cancer: Clinical implications for minimizing post-radiotherapy swallowing dysfunction.
    Kil WJ; Kulasekere C; Hatch C; Bugno J; Derrwaldt R
    Head Neck; 2017 Aug; 39(8):E85-E91. PubMed ID: 28475284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensity-modulated radiotherapy for oropharyngeal squamous cell carcinoma.
    Mendenhall WM; Amdur RJ; Morris CG; Kirwan JM; Li JG
    Laryngoscope; 2010 Nov; 120(11):2218-22. PubMed ID: 20938964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there a "mucosa-sparing" benefit of IMRT for head-and-neck cancer?
    Sanguineti G; Endres EJ; Gunn BG; Parker B
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):931-8. PubMed ID: 17011465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Dose to an Oral Mucosa Organ at Risk Predict the Duration of Grade 3 Mucositis after Intensity-modulated Radiotherapy for Oropharyngeal Cancer?
    Yahya S; Benghiat H; Nightingale P; Tiffany M; Sanghera P; Hartley A
    Clin Oncol (R Coll Radiol); 2016 Dec; 28(12):e216-e219. PubMed ID: 27593973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: Dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy.
    MD Anderson Head and Neck Cancer Symptom Working Group
    Radiother Oncol; 2016 Feb; 118(2):304-14. PubMed ID: 26897515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT.
    Vanetti E; Clivio A; Nicolini G; Fogliata A; Ghosh-Laskar S; Agarwal JP; Upreti RR; Budrukkar A; Murthy V; Deshpande DD; Shrivastava SK; Dinshaw KA; Cozzi L
    Radiother Oncol; 2009 Jul; 92(1):111-7. PubMed ID: 19157609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of submandibular gland and swallowing structure sparing to post-radiation therapy PEG dependence in oropharynx cancer patients treated with split-neck IMRT technique.
    Gensheimer MF; Nyflot M; Laramore GE; Liao JJ; Parvathaneni U
    Radiat Oncol; 2016 Nov; 11(1):151. PubMed ID: 27846899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.